DARING-B: Discontinuation of effective entecavir (ETV) or tenofovir (TDF) therapy in non-cirrhotic HBeAg-negative chronic hepatitis B (CHBe-) patients: a prospective Greek study
Reported by Jules Levin
EASL 2017 April 19-21 Amsterdam, Netherlands
George Papatheodoridis1, Eirini Rigopoulou2, Margarita Papatheodoridi1, Kalliopi Zachou2, Vasilis Xourafas1, Nikolaos Gatselis2, John Vlachogiannakos1, George Dalekos2
1Academic Department of Gastroenterology, Medical School of National and Kapodistrian University of Athens, Laiko General Hospital, Athens, Greece; 2Department of Medicine and Research Laboratory of Internal Medicine, Thessalia University Medical School, Larissa, Greece.
